Rolfo, CHRISTIAN DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 3.770
EU - Europa 1.500
AS - Asia 1.011
AF - Africa 61
SA - Sud America 59
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.435
Nazione #
US - Stati Uniti d'America 3.690
FR - Francia 499
CN - Cina 494
IT - Italia 354
JP - Giappone 217
DE - Germania 196
GB - Regno Unito 79
CA - Canada 68
IN - India 63
UA - Ucraina 56
KR - Corea 49
NL - Olanda 42
ES - Italia 39
IE - Irlanda 37
RU - Federazione Russa 35
BR - Brasile 33
ZA - Sudafrica 33
TW - Taiwan 32
VN - Vietnam 29
EG - Egitto 25
HK - Hong Kong 24
AU - Australia 20
CZ - Repubblica Ceca 19
AT - Austria 17
BE - Belgio 17
ID - Indonesia 17
IR - Iran 16
RO - Romania 16
TR - Turchia 15
PL - Polonia 13
FI - Finlandia 12
MX - Messico 11
CL - Cile 10
GR - Grecia 10
PT - Portogallo 10
SE - Svezia 10
HU - Ungheria 9
NZ - Nuova Zelanda 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
SG - Singapore 8
CO - Colombia 7
PE - Perù 7
PK - Pakistan 7
DK - Danimarca 5
IL - Israele 5
TH - Thailandia 5
EU - Europa 4
MY - Malesia 4
PH - Filippine 4
CY - Cipro 3
HR - Croazia 3
KW - Kuwait 3
NO - Norvegia 3
AR - Argentina 2
BG - Bulgaria 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BT - Bhutan 1
EE - Estonia 1
HN - Honduras 1
IQ - Iraq 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.435
Città #
Fairfield 515
Houston 347
Ashburn 311
Woodbridge 285
Seattle 260
Buffalo 195
Cambridge 188
Des Moines 183
Wilmington 160
Santa Cruz 154
Ann Arbor 120
Palermo 108
Wuhan 83
Beijing 71
Ekimaedori 58
Shanghai 43
Tokyo 42
Mountain View 37
Las Vegas 34
Hanawada 32
Rome 32
University Park 31
Dublin 30
Los Angeles 28
Hanoi 27
Nanjing 27
Muizenberg 25
Ottawa 23
San Diego 22
Guangzhou 21
Phoenix 21
Boardman 20
Chicago 20
Clearwater 19
Mumbai 19
Seoul 19
Taipei 18
Henderson 15
Hangzhou 14
Milan 14
New York 14
Tianjin 12
Toronto 11
Duncan 10
Düsseldorf 10
Madrid 10
Saiwaicho 10
San Jose 10
Bengaluru 9
Chongqing 9
Riva 9
Scranton 9
Changsha 8
Chengdu 8
Dallas 8
Helsinki 8
Polska 8
Atlanta 7
Central 7
Jakarta 7
Lima 7
Nashville 7
Portland 7
Provo 7
Athens 6
Bologna 6
Bucaramanga 6
Cairo 6
Clarks Summit 6
London 6
San Francisco 6
Shaoxing 6
Sydney 6
São Paulo 6
Xian 6
Bangkok 5
Easton 5
Fremont 5
Leuven 5
Magenta 5
Menlo Park 5
Milpitas 5
Montreal 5
Oberhausen 5
Passau 5
Recife 5
Rochester 5
Rostov-on-Don 5
Shenyang 5
Takajomachi 5
Turin 5
Utrecht 5
Zhengzhou 5
Amsterdam 4
Bondy 4
Bucharest 4
Central District 4
Denver 4
Genoa 4
Grenoble 4
Totale 4.067
Nome #
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis, file e3ad891c-7bb9-da0e-e053-3705fe0a2b96 951
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor, file e3ad891b-c823-da0e-e053-3705fe0a2b96 698
Cancer and the microbiome: Potential applications as new tumor biomarker, file e3ad891b-d8b8-da0e-e053-3705fe0a2b96 490
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma, file e3ad8919-b376-da0e-e053-3705fe0a2b96 337
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting, file e3ad8916-d0dc-da0e-e053-3705fe0a2b96 277
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells, file e3ad8918-1cc6-da0e-e053-3705fe0a2b96 265
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario, file e3ad891a-fee9-da0e-e053-3705fe0a2b96 257
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis, file e3ad8919-b5e4-da0e-e053-3705fe0a2b96 240
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21, file e3ad8919-0f14-da0e-e053-3705fe0a2b96 219
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis, file e3ad8918-7888-da0e-e053-3705fe0a2b96 216
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC), file e3ad891b-3782-da0e-e053-3705fe0a2b96 207
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice, file e3ad8919-0f17-da0e-e053-3705fe0a2b96 205
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis?, file e3ad891d-38af-da0e-e053-3705fe0a2b96 180
Multisciplinary management of patients with liver metastasis from colorectal cancer, file e3ad891b-dca1-da0e-e053-3705fe0a2b96 170
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS?, file e3ad8919-6933-da0e-e053-3705fe0a2b96 162
Targeting angiogenesis in biliary tract cancers: An open option, file e3ad891b-9b24-da0e-e053-3705fe0a2b96 159
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward, file e3ad891b-ef6e-da0e-e053-3705fe0a2b96 156
VIPoma and PPoma, file e3ad891c-e4ea-da0e-e053-3705fe0a2b96 152
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib, file e3ad891b-7d82-da0e-e053-3705fe0a2b96 147
Exosomes in semen: Opportunities as a new tool in prostate cancer diagnosis, file e3ad891b-9b30-da0e-e053-3705fe0a2b96 146
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…, file e3ad891c-fbf0-da0e-e053-3705fe0a2b96 138
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter, file e3ad891d-06d1-da0e-e053-3705fe0a2b96 135
Improving extracellular vesicles visualization: From static to motion, file e3ad8921-de01-da0e-e053-3705fe0a2b96 115
Exosomes as diagnostic and predictive biomarkers in lung cancer, file e3ad891b-d34b-da0e-e053-3705fe0a2b96 114
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition, file e3ad891b-572e-da0e-e053-3705fe0a2b96 106
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment, file e3ad891d-d300-da0e-e053-3705fe0a2b96 105
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis, file bde11d1e-a3c7-4772-a073-473b4c78c72c 74
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials, file e3ad8927-4bd7-da0e-e053-3705fe0a2b96 70
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?, file e3ad891b-5ebe-da0e-e053-3705fe0a2b96 57
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it, file e3ad891c-eddd-da0e-e053-3705fe0a2b96 40
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target?, file e3ad891d-1452-da0e-e053-3705fe0a2b96 25
Role of NSCLC exosomes in osteoclast differentiation, file e3ad891d-8056-da0e-e053-3705fe0a2b96 19
Role of NSCLC exosomes in osteoclast differentiation, file e3ad891d-7682-da0e-e053-3705fe0a2b96 11
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors, file 289a73e9-e7c2-4b5d-a817-87469746427b 7
Effects of exosomes released by NSCLC cells on osteoclasts differentiation., file e3ad8920-304d-da0e-e053-3705fe0a2b96 7
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance, file e3ad891b-9ad8-da0e-e053-3705fe0a2b96 6
null, file c8735aa6-d9d5-409b-a4e7-a2f1b51241c6 5
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia cells, file 1da5f090-5de9-4121-9ceb-7030ff1eb92e 4
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy, file e3ad8919-8e1b-da0e-e053-3705fe0a2b96 3
Ramucirumab and its use in gastric cancer treatment, file e3ad8919-d35c-da0e-e053-3705fe0a2b96 3
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential, file e3ad891d-b5e9-da0e-e053-3705fe0a2b96 2
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546], file e3ad8923-ae65-da0e-e053-3705fe0a2b96 2
Liquid biopsy: a right tool in a right context?, file 1fd99aaf-ec1a-49b4-93e6-a39c4cabb2ca 1
BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door?, file e3ad891d-bfc5-da0e-e053-3705fe0a2b96 1
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy, file e3ad891e-3567-da0e-e053-3705fe0a2b96 1
Totale 6.685
Categoria #
all - tutte 12.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019417 0 0 0 0 0 0 0 0 0 118 170 129
2019/20201.819 121 126 138 373 177 139 119 134 140 116 108 128
2020/20211.092 93 71 105 108 100 94 109 90 111 83 87 41
2021/2022810 59 61 48 128 82 39 39 49 39 32 177 57
2022/2023837 25 38 171 122 63 72 197 20 37 25 60 7
2023/2024821 19 26 46 38 51 37 251 306 18 29 0 0
Totale 6.685